Latest Stories

M
Screener

2 Healthcare Stocks with Solid Fundamentals and 1 That Underwhelm

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 22% gain over the past six months, beating the S&P 500 by 14.2 percentage points.

Jan 22, 2026
C
Screener

1 Mooning Stock to Keep an Eye On and 2 We Ignore

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.

Jan 22, 2026
G
Screener

3 Cash-Producing Stocks with Open Questions

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.

Jan 22, 2026
A
Screener

3 Unprofitable Stocks with Warning Signs

Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.

Jan 22, 2026
U
Screener

1 S&P 500 Stock Worth Your Attention and 2 That Underwhelm

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

Jan 22, 2026
M
Screener

1 Unpopular Stock That Deserves a Second Chance and 2 That Underwhelm

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Jan 22, 2026
O
Screener

1 Momentum Stock Worth Your Attention and 2 We Turn Down

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.

Jan 22, 2026
B
Screener

1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 Facing Headwinds

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Jan 22, 2026
A
Screener

2 Volatile Stocks to Target This Week and 1 We Question

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

Jan 22, 2026
K
Screener

1 Unpopular Stock That Deserves Some Love and 2 We Question

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

Jan 22, 2026